Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Receivables (2020 - 2025)

MDxHealth (MDXH) has disclosed Receivables for 6 consecutive years, with $14.7 million as the latest value for Q4 2025.

  • Quarterly Receivables rose 1.63% to $14.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.7 million through Dec 2025, up 1.63% year-over-year, with the annual reading at $14.7 million for FY2025, 1.63% up from the prior year.
  • Receivables hit $14.7 million in Q4 2025 for MDxHealth, up from $14.4 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $18.7 million in Q4 2022 to a low of $9.2 million in Q4 2021.
  • Historically, Receivables has averaged $13.6 million across 5 years, with a median of $14.4 million in 2024.
  • Biggest five-year swings in Receivables: skyrocketed 104.21% in 2022 and later tumbled 40.56% in 2023.
  • Year by year, Receivables stood at $9.2 million in 2021, then surged by 104.21% to $18.7 million in 2022, then crashed by 40.56% to $11.1 million in 2023, then increased by 29.81% to $14.4 million in 2024, then rose by 1.63% to $14.7 million in 2025.
  • Business Quant data shows Receivables for MDXH at $14.7 million in Q4 2025, $14.4 million in Q4 2024, and $11.1 million in Q4 2023.